Jump to content

Talk:Adenosine monophosphate deaminase deficiency type 1

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 67.189.56.3 (talk) at 03:10, 15 August 2011 (CHANGE PAGE NAME ??). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

WikiProject iconMedicine Start‑class Mid‑importance
WikiProject iconThis article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.
StartThis article has been rated as Start-class on Wikipedia's content assessment scale.
MidThis article has been rated as Mid-importance on the project's importance scale.

Requested move

Myoadenylate deaminase deficiencyAdenosine Monophosphate Deaminase Deficiency type 1 (AMPD1)

The primary name for Myoadenlylate Deaminase Deficiency (MAD or MADD) has been changed in the last decade, as referenced below by: Orphanet (Rare Disease Research) - 36 countries are members. US National Institutes of Health (NIH).

See the following references. [1] [2] Cite error: A <ref> tag is missing the closing </ref> (see the help page). 67.189.56.3 (talk) 02:59, 15 August 2011 (UTC)Tom[reply]

  1. ^ {cite web |url=http://ghr.nlm.nih.gov/gene/AMPD1 |title=AMPD1 Gene]]
  2. ^ {cite web |url=http://ghr.nlm.nih.gov/condition/adenosine-monophosphate-deaminase-deficiency |title=Adenosine monophosphate deaminase deficiency}}